Carol Giltner Gallagher's Net Worth

$9.94 Million

Estimate Recalculated Nov 3, 2024 09:37PM EST

Who is Carol Giltner Gallagher?

Carol Giltner Gallagher has an estimated net worth of $9.94 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., Atara Biotherapeutics, Inc., ANAPTYSBIO INC, Certara, Inc., Frazier Lifesciences Acquisition Corp, Metacrine, Inc., Millendo Therapeutics, Inc., Annexon, Inc., Mirati Therapeutics, Inc., PMV Pharmaceuticals, Inc., ANADYS PHARMACEUTICALS INC, and CANCERVAX CORP.

SEC CIK

Carol Giltner Gallagher's CIK is 0001329959

Past Insider Trading and Trends

2017 was Carol Giltner Gallagher's most active year for acquiring shares with 14 total transactions. Carol Giltner Gallagher's most active month to acquire stocks was the month of May. 2015 was Carol Giltner Gallagher's most active year for disposing of shares, totalling 18 transactions. Carol Giltner Gallagher's most active month to dispose stocks was the month of July. 2023 saw Carol Giltner Gallagher paying a total of $468,184.47 for 455,147 shares, this is the most they've acquired in one year. In 2018 Carol Giltner Gallagher cashed out on 28,240 shares for a total of $957,114.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 17
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Aug 27 - Jun 15
Form 4
—
0
—
—
0
Jul 24
Form 3
—
0
—
—
0
No matching records found

Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $9.1465

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.28%
150K
—
—
629.61K
Mar 31
Form 4
+142.54%
270K
$0.25
$68,214.48
459.42K
Nov 13 - Nov 14
Form 4
+43.05%
57K
—
—
189.42K
May 31
Form 4
+18.32%
20.5K
—
—
132.42K
Jun 23
Form 4
+10.91%
11K
—
—
111.82K
Jun 8
Form 4
+8.62%
8K
—
—
100.82K
Jun 16
Form 4
+4.50%
4K
—
—
92.82K
Jun 27
Form 4
-19.40%
-21.37K
$36.38
-$777,586.12
88.82K
Nov 7
Form 4
-2.22%
-2.50K
$44.78
-$111,944.00
110.19K
Scheduled
Jun 18
Form 4
+1.35%
1.5K
—
—
112.69K
Jun 14
Form 4
+0.25%
272
$46.06
-$12,574.38
111.19K
Scheduled
May 15 - May 16
Form 4
+1.08%
1.18K
$46.50
-$55,009.50
110.92K
Scheduled
Feb 15 - Feb 16
Form 4
+1.09%
1.18K
$14.20
-$16,812.80
109.74K
Scheduled
Nov 15 - Nov 16
Form 4
+1.10%
1.18K
$14.30
-$16,931.20
108.56K
Scheduled
Aug 15 - Aug 16
Form 4
+3.87%
4K
$13.15
-$13,150.00
107.37K
Scheduled
Jun 8 - Jun 9
Form 4
+1.16%
1.18K
$15.25
-$18,056.00
103.37K
Scheduled
May 15 - May 16
Form 4
+1.17%
1.18K
$16.10
-$19,046.30
102.19K
Scheduled
Feb 15 - Feb 16
Form 4
+2.02%
2K
—
—
101.01K
Jan 3
Form 4
+1.21%
1.18K
$19.35
-$22,910.40
99.01K
Scheduled
Nov 15 - Nov 16
Form 4
+2.48%
2.37K
—
—
97.83K
Aug 15
Form 4
+1.25%
1.18K
$15.96
-$18,896.64
95.46K
Scheduled
May 16 - May 18
Form 4
+1.27%
1.18K
$16.30
-$19,282.90
94.28K
Scheduled
Feb 16 - Feb 17
Form 4
—
0
—
—
0
Jan 4
Form 4
+1.29%
1.18K
$31.10
-$36,822.40
93.1K
Scheduled
Nov 16 - Nov 17
Form 4
-16.09%
-17.62K
$42.34
-$746,090.26
91.92K
Scheduled
Aug 20 - Aug 24
Form 4
+74.82%
46.88K
$48.78
-$567,708.82
109.54K
Scheduled
Aug 17 - Aug 19
Form 4
+21.29%
11K
$18.00
$198,000.00
62.66K
Feb 18
Form 4
—
0
—
—
0
Jan 16
Form 4
∞
51.66K
$11.00
—
51.66K
Oct 21
Form 3
—
0
—
—
0
No matching records found

ANAPTYSBIO INC (ANAB) Snapshot price: $35.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 2
Form 4
—
0
—
—
0
Feb 24
Form 4
∞
64.3K
—
—
64.3K
Jan 31
Form 3
—
0
—
—
0
No matching records found

Certara, Inc. (CERT) Snapshot price: $11.39

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
7.06K
—
—
7.06K
Jun 15
Form 3
—
0
—
—
0
No matching records found

Frazier Lifesciences Acquisition Corp No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 22
Form 3/A
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found